Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone

Journal of Physiology and Pharmacology

Volumn 48, Issue 4, 1997, Pages 675-688

  Ruetten, H ^a   Thiemermann, Ch ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dexamethasone rat; Endothelin 1; ET(A) receptor; ET(B) receptor protein tyrosine kinase; Tumour necrosis factor

Indexed keywords

CELL PROTEIN; DEXAMETHASONE; ENDOTHELIN 1; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; CELL CULTURE; CONFERENCE PAPER; GENETIC TRANSCRIPTION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; RNA TRANSLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL SURVIVAL; DEXAMETHASONE; ENDOTHELIN-1; INTERFERON TYPE II; MACROPHAGES; MALE; MICE; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031454193     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Beutler B, Cerami A. The biology of cachectin/TNFα a primary mediator of the host defence. Annual Rev Immunol 1989; 7: 625-655.
2. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biology 1988; 107: 1269-1277.
3. Warner SJC, Libby P. Human vascular smooth muscle cells target for and source of tumour necrosis factor. J Immunol 1989; 142: 100-107.
4. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumour necrosis factor alpha. Proc Natl Acad Sci USA 1990; 87: 6758-6761.
5. Vassalli P. The pathophysiology of tumour necrosis factors. Annual Rev Immunol 1992; 10: 411-452.
6. Billiau A, Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 1991; 21: 559-573.
7. Pober JS, Bevilacqua M, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA. Two distinct monokines, interleukin 1 and tumour necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680-1687.
8. Kilbourn RG, Belloni, P. Endothelial cell proliferation of nitrigen oxides in response to interferon-gamma in combination with tumour necrosis factor, interleukin-1 or endotoxin. J Natl Cancer Inst 1990; 82: 772-776.
9. Szabo C, Thiemermann C. Regulation of the expression of inducible nitric oxide synthase. Adv Pharmacol 1995; 34: 113-159.
10. Inoue A, Yanagisawa M, Kimura S et al. The human endothelin family: three structually and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989; 86: 2863-2876.
11. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732.
12. Sakurai T, Yanagisawa M, Takuwa Y et al. Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 1990; 348: 732-735.
13. Ihara M, Saeki T, Funabashi K et al. Two endothelin receptor subtypes in porcine arteries. J Cardiovasc Pharmacol 1991; 17 (Suppl.17): 119-121.
14. Davenport AP, O'Reilly G, Kuc RE. Endothelin ET(a) and ET(b) mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ET(a) subtype. Br J Pharmacol 1995; 114: 1110-1116.
15. De Nucci G, Thomas GR, D'Orleans-Juste P et al. The pressor effects of circulating endothelin are limited by ist removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800.
16. Thiemermann C, Lidbury PS, Thomas GR, Vane JR. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anaesthetized rabbit. J Cardiovasc Pharmacol 1989; 13 (Suppl.5): 138-141.
17. Yanagisawa M, Masaki T. Molecular biology and biochemestry of endothelins. Trends Pharmacol Sci 1989; 10: 374-378.
18. Masaki T, Yanagisawa M. Cardivascular effects of the endothelins. Cardiovasc Drug Rev, 1990; 8: 373-385.
19. Rubanyi GM, Parker-Botelho LH. Endothelins. FASEB J 1991; 5: 2713-2720.
20. Huggins JP, Pelton JT, Miller RC. The structure and specifity of endothelin receptors: their importance in physiology and medicine. Pharmac Ther 1993; 59: 55-123.
21. Ehrenreich H, Anderson RW, Fox CH et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172: 1741-1748.
22. Sessa WC, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991; 174: 613-615.
23. Brain SD, Crossman DC, Buckley TL, Williams TJ. Endothelin-1: demonstration of potent effects on the microcirculation of humans and other species. J Cardiovasc Pharmacol 1989; 13: 147-150.
24. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989; 161: 1220-1227.
25. Nakamura T, Kasai K, Sekiguchi Y et al. Elevation of plasma endothelin concentration during endotoxin shock in dogs. Eur J Pharmacol 1991; 205: 277-282.
26. Pittet JF, Morel DR, Hemsen A et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991; 213: 261-264.
27. Yoshizumi M, Kurihara H, Sugiyama T et al. Haemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989; 161: 859-864.
28. Vemulapalli S, Chiu PJ, Rivelli M, Foster CJ, Sybertz EJ. Modulation of circulating endothelin levels in hypertension and endotoxaemia in rats. J Cardiovasc Pharmacol 1991; 18: 895-903.
29. Yamashita J, Ogawa M, Nomura K et al. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res 1993; 53: 464-467.
30. Klemm P, Warner TD, Hohlfeld T, Corder R, Vane JR. Endothelin mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Nat. Acad Sci USA 1995; 92: 2691-2695.
31. Xin X, Cai Y, Matsumoto K, Agui T. Endothelin-induced interleukin-6 production by rat aortic endothelial cells. Endocrinology 1995; 136: 132-137.
32. Agui T, Xin X, Cai Y, Sakai T, Matsumoto, K. Stimulation of interleukin-6 production by endothelin in rat bone marrow-derived stromal cells. Blood 1994; 84: 2531-2538.
33. Ruetten H, Thiemermann C, Vane JR. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Br J Pharmacol 1996; 118: 198-204.
34. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1992; 86: 1375-1379.
35. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial ceels. Proc Natl Acad Sci USA 1990; 87: 10043-10047.
36. Wu CC, Croxtall JD, Perretti M et al. Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci USA 1995; 92: 3473-3477.
37. Flower RJ, Rothwell NJ. Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994; 15: 71-76.
38. Nakahashi T, Fukuo K, Inoue T et al. Endothelin-1 enhances nitric oxide-induced cytotoxicity in vascular smooth muscle. Hypertension 1995; 25: 744-747.
39. Ishikawa K, Ihara M, Noguchi K et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994; 91: 4892-4896.
40. Mossman, T. Rapid caloimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983; 65: 55-63.
41. Kengatheran M, De Kimpe SJ, Thiemermann C. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol 1996; 117: 1163-1170.
42. 2+ mobilization through its specific receptors in murine peritoneal macrophages. FEBS Lett 1991; 280: 103-106.
43. Akarasereenont P, Thiemermann C. The induction of cyclo-oxygenase in human pulmonary epithelial cell culture (A549) activated by IL-1β is inhibited by tyrosine kinase inhibitors. Biochem Biophys Res Commun 1996; 220: 181-185.
44. Simonson MS, Herman WH. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. J Biol Chem 1993; 268: 9347-9357.
45. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumour necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990; 172: 391-394.
46. 2 and TNF alpha release from human peripheral blood mononuclear cells. Br J Pharmacol 1996; 117: 1449-1456.
47. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994; 199: 1461-1465.